89 related articles for article (PubMed ID: 34452314)
1. Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.
Miller TR; Weiss JJ; Bräu N; Dieterich DT; Stivala A; Rivera-Mindt M
J Neurovirol; 2017 Apr; 23(2):260-272. PubMed ID: 27896573
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic issues in HIV/HCV-coinfected patients.
Sulkowski MS; Benhamou Y
J Viral Hepat; 2007 Jun; 14(6):371-86. PubMed ID: 17501757
[TBL] [Abstract][Full Text] [Related]
3. IL28B SNP rs8099917 is strongly associated with pegylated interferon-α and ribavirin therapy treatment failure in HCV/HIV-1 coinfected patients.
Aparicio E; Parera M; Franco S; Pérez-Alvarez N; Tural C; Clotet B; Martínez MA
PLoS One; 2010 Oct; 5(10):e13771. PubMed ID: 21048934
[TBL] [Abstract][Full Text] [Related]
4. High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.
Gonzalez VD; Falconer K; Blom KG; Reichard O; Mørn B; Laursen AL; Weis N; Alaeus A; Sandberg JK
J Virol; 2009 Nov; 83(21):11407-11. PubMed ID: 19710147
[TBL] [Abstract][Full Text] [Related]
5. Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
Kushner LE; Wendelboe AM; Lazzeroni LC; Chary A; Winters MA; Osinusi A; Kottilil S; Polis MA; Holodniy M
PLoS One; 2013; 8(4):e60387. PubMed ID: 23593207
[TBL] [Abstract][Full Text] [Related]
6. Interferon stimulated exonuclease gene 20 kDa links psychiatric events to distinct hepatitis C virus responses in human immunodeficiency virus positive patients.
Katsounas A; Rasimas JJ; Schlaak JF; Lempicki RA; Rosenstein DL; Kottilil S
J Med Virol; 2014 Aug; 86(8):1323-31. PubMed ID: 24782267
[TBL] [Abstract][Full Text] [Related]
7. Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centers.
Butt AA; Khan UA; Shaikh OS; McMahon D; Dorey-Stein Z; Tsevat J; Lo Re V
HIV Clin Trials; 2009; 10(1):25-32. PubMed ID: 19362993
[TBL] [Abstract][Full Text] [Related]
8. Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
Abdel-Mohsen M; Deng X; Danesh A; Liegler T; Jacobs ES; Rauch A; Ledergerber B; Norris PJ; Günthard HF; Wong JK; Pillai SK
PLoS One; 2014; 9(10):e109220. PubMed ID: 25275557
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing adherence in Hepatitis-C infected patients: a systematic review.
Mathes T; Antoine SL; Pieper D
BMC Infect Dis; 2014 Apr; 14():203. PubMed ID: 24731285
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review.
Hepworth J; Bain T; van Driel M
Int J Equity Health; 2013 Nov; 12():92. PubMed ID: 24245959
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy for hepatitis C virus: beyond the standard of care.
Delang L; Coelmont L; Neyts J
Viruses; 2010 Apr; 2(4):826-866. PubMed ID: 21994657
[TBL] [Abstract][Full Text] [Related]
12. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo.
Abdel-Mohsen M; Deng X; Liegler T; Guatelli JC; Salama MS; Ghanem Hel-D; Rauch A; Ledergerber B; Deeks SG; Günthard HF; Wong JK; Pillai SK
J Virol; 2014 Jan; 88(1):763-7. PubMed ID: 24155399
[TBL] [Abstract][Full Text] [Related]
13. Microarrays-Enabled Hypothesis Generation: The Suspect Role of FNBP-1 in Neuropsychiatric Pathogenesis Associated with HIV and/or HCV Infection.
Katsounas A; Wilting KR; Lempicki RA; Schlaak JF; Gerken G
J AIDS Clin Res; 2016 Dec; 7(12):. PubMed ID: 28255515
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene Glycol-Modified Cationic Liposome as a Promising Nano Spray for Acute Pneumonia Treatment.
Wang K; Chen D; Zhang C; Lu L; Shang F; Li Y
Polymers (Basel); 2024 May; 16(10):. PubMed ID: 38794576
[TBL] [Abstract][Full Text] [Related]
15. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment.
Lu J; Xing H; Wang C; Tang M; Wu C; Ye F; Yin L; Yang Y; Tan W; Shen L
Signal Transduct Target Ther; 2023 Dec; 8(1):458. PubMed ID: 38148355
[TBL] [Abstract][Full Text] [Related]
16. Gamma-Delta T-Cell Phenotype and Function in DAA-Treated HIV-HCV Co-Infected and HCV-Mono-Infected Subjects.
Bono V; Tincati C; Van Den Bogaart L; Cannizzo ES; Rovito R; Augello M; De Bona A; D'Arminio Monforte A; Milazzo L; Marchetti G
Viruses; 2022 Jul; 14(8):. PubMed ID: 35893661
[TBL] [Abstract][Full Text] [Related]
17. Combined Effects of Fludarabine and Interferon Alpha on Autophagy Regulation Define the Phase of Cell Survival and Promotes Responses in LLC-MK2 and K562 Cells.
Bowornruangrit P; Kumkate S; Sirigulpanit W; Leardkamolkarn V
Med Sci (Basel); 2022 Mar; 10(1):. PubMed ID: 35323219
[TBL] [Abstract][Full Text] [Related]
18. Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients.
Grubczak K; Grzeszczuk A; Groth M; Hryniewicz A; Kretowska-Grunwald A; Flisiak R; Moniuszko M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452314
[TBL] [Abstract][Full Text] [Related]
19. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Ramos B; Núñez M; Rendón A; Berdún MA; Losada E; Santos I; Echevarría S; Ocampo A; Miralles C; Arazo P; Barreiro P; Romero M; Labarga P; Guardiola JM; Garcia-Samaniego J; Soriano V
J Viral Hepat; 2007 Jun; 14(6):387-91. PubMed ID: 17501758
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
